PPM1D Mutations in Patients with Hematolymphoid Neoplasms

被引：0

作者：

Streich, Lukas ^{[1
]}

Fisher-Campbell, Nora ^{[1
]}

Magallanes-Hoyos, M. Cristina ^{[1
]}

Gandhi, Arpita ^{[1
]}

Li, Peng ^{[2
]}

Wang, Sa ^{[3
]}

Tang, Guilin ^{[3
]}

Wang, Wei ^{[3
]}

Wiszniewska, Joanna ^{[1
]}

Dunlap, Jennifer ^{[1
]}

Raess, Phil ^{[1
]}

Williams, Todd ^{[1
]}

Press, Richard ^{[1
]}

Fan, Guang ^{[1
]}

Xie, Wei ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR USA

[2] Univ Utah, ARUP Labs, Salt Lake City, UT USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1197

引用

页码：S1244 / S1245

页数：2

共 50 条

[21] PPM1D and DNMT3A Mutations in Myelodysplasia and Clonal Hematopoiesis
Motomura, Masanori
Inoue, Yoshikage
Nagata, Yasunobu
Yoshizato, Tetsuichi
Baer, Constance
Momozawa, Yukihide
Nadarajah, Niroshan
Nannya, Yasuhito
Yoshida, Kenichi
Haferlach, Claudia
Kern, Wolfgang
Atsuta, Yoshiko
Iijima-Yamashita, Yuka
Shiraishi, Yuichi
Onizuka, Makoto
Chiba, Kenichi
Tanaka, Hiroko
Itonaga, Hidehiro
Miyazaki, Yasushi
Horibe, Keizo
Sanada, Masashi
Kamatani, Yoichiro
Kubo, Michiaki
Miyano, Satoru
Haferlach, Torsten
Ogawa, Seishi
Makishima, Hideki
BLOOD, 2019, 134
[22] Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q
Panagiota, Victoria
Meggendorfer, Manja
Kubasch, Anne Sophie
Gabdoulline, Razif
Kroenke, Jan
Mies, Anna
Shahswar, Rabia
Kandziora, Christian
Klement, Piroska
Schiller, Johannes
Goehring, Gudrun
Haferlach, Claudia
Ganster, Christina
Shirneshan, Katayoon
Gutermuth, Annika
Thiede, Christian
Germing, Ulrich
Schroeder, Thomas
Kobbe, Guido
Klesse, Sabrina
Koenecke, Christian
Schlegelberger, Brigitte
Kroeger, Nicolaus
Haase, Detlef
Doehner, Konstanze
Sperr, Wolfgang R.
Valent, Peter
Ganser, Arnold
Thol, Felicitas
Haferlach, Torsten
Platzbecker, Uwe
Heuser, Michael
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : E207 - E210
[23] Somatic mutations in PPM1D and TP53 in patients with myelodysplastic syndromes and complex aberrations
Eder, L. N.
Ganster, C.
Shirneshan, K.
Schaab, R.
Martin, R.
Dierks, S.
Haase, D.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 95 - 96
[24] Detectible mosaic truncating PPM1D mutations, age and breast cancer risk
Machiela, Mitchell J.
Myers, Timothy A.
Lyons, Christopher J.
Koster, Roelof
Figg, William D., Jr.
Colli, Leandro M.
Jessop, Lea
Ahearn, Thomas U.
Freedman, Neal D.
Garcia-Closas, Montserrat
Chanock, Stephen J.
JOURNAL OF HUMAN GENETICS, 2019, 64 (06) : 545 - 550
[25] Truncating and Missense PPM1D Mutations in Early-Onset and/or Familial/Hereditary Prostate Cancer Patients
Cardoso, Marta
Paulo, Paula
Maia, Sofia
Teixeira, Manuel R.
GENES CHROMOSOMES & CANCER, 2016, 55 (12): : 954 - 961
[26] PPM1D Mutations in Circulating White Blood Cells and the Risk for Ovarian Cancer
Akbari, Mohammad R.
Lepage, Pierre
Rosen, Barry
McLaughlin, John
Risch, Harvey
Minden, Mark
Narod, Steven A.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (01):
[27] Prognostic value of PPM1D in 800 gastric cancer patients
Ma, Dan
Zhang, Chao-Jun
Chen, Zu-Lin
Yang, Hua
MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 191 - 194
[28] Detectible mosaic truncating PPM1D mutations, age and breast cancer risk
Mitchell J. Machiela
Timothy A. Myers
Christopher J. Lyons
Roelof Koster
William D. Figg
Leandro M. Colli
Lea Jessop
Thomas U. Ahearn
Neal D. Freedman
Montserrat García-Closas
Stephen J. Chanock
Journal of Human Genetics, 2019, 64 : 545 - 550
[29] A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D (vol 27, pg 1036, 2008)
Rayter, S.
Elliott, R.
Travers, J.
Rowlands, M. G.
Richardson, T. B.
Boxall, K.
Jones, K.
Linardopoulos, S.
Workman, P.
Aherne, W.
Lord, C. J.
Ashworth, A.
ONCOGENE, 2020, 39 (24) : 4780 - 4780
[30] RE: PPM1D Mutations in Circulating White Blood Cells and the Risk for Ovarian Cancer
Qiu, Haifeng
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (04):

← 1 2 3 4 5 →